Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention

被引:254
作者
Lieberman, J. A. [1 ,2 ]
Girgis, R. R. [1 ,2 ]
Brucato, G. [1 ,2 ]
Moore, H. [1 ,2 ]
Provenzano, F. [3 ]
Kegeles, L. [1 ,2 ]
Javitt, D. [1 ,2 ]
Kantrowitz, J. [1 ,2 ]
Wall, M. M. [1 ,2 ,4 ]
Corcoran, C. M. [1 ]
Schobel, S. A. [1 ]
Small, S. A. [1 ,3 ,5 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
[4] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA
[5] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; GLUTAMATE-RECEPTOR AGONIST; CEREBRAL-BLOOD-FLOW; IN-VIVO; 1ST-EPISODE SCHIZOPHRENIA; DENTATE GYRUS; BRAIN VOLUME; KETAMINE; PSYCHOSIS; EXPRESSION;
D O I
10.1038/mp.2017.249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Scientists have long sought to characterize the pathophysiologic basis of schizophrenia and develop biomarkers that could identify the illness. Extensive postmortem and in vivo neuroimaging research has described the early involvement of the hippocampus in the pathophysiology of schizophrenia. In this context, we have developed a hypothesis that describes the evolution of schizophrenia-from the premorbid through the prodromal stages to syndromal psychosis-and posits dysregulation of glutamate neurotransmission beginning in the CA1 region of the hippocampus as inducing attenuated psychotic symptoms and initiating the transition to syndromal psychosis. As the illness progresses, this pathological process expands to other regions of the hippocampal circuit and projection fields in other anatomic areas including the frontal cortex, and induces an atrophic process in which hippocampal neuropil is reduced and interneurons are lost. This paper will describe the studies of our group and other investigators supporting this pathophysiological hypothesis, as well as its implications for early detection and therapeutic intervention.
引用
收藏
页码:1764 / 1772
页数:9
相关论文
共 89 条
[81]   Statistical shape analysis of neuroanatomical structures based on medial models [J].
Styner, M ;
Gerig, G ;
Lieberman, J ;
Jones, D ;
Weinberger, D .
MEDICAL IMAGE ANALYSIS, 2003, 7 (03) :207-220
[82]   Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [F-18]fluorodeoxyglucose (FDG) [J].
Vollenweider, FX ;
Leenders, KL ;
Scharfetter, C ;
Antonini, A ;
Maguire, P ;
Missimer, J ;
Angst, J .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (01) :9-24
[83]   Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture [J].
Vutskits, Laszlo ;
Gascon, Eduardo ;
Potter, Gael ;
Tassonyi, Edomer ;
Kiss, Jozsef Z. .
TOXICOLOGY, 2007, 234 (03) :216-226
[84]   Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia [J].
Walsh, Tom ;
McClellan, Jon M. ;
McCarthy, Shane E. ;
Addington, Anjene M. ;
Pierce, Sarah B. ;
Cooper, Greg M. ;
Nord, Alex S. ;
Kusenda, Mary ;
Malhotra, Dheeraj ;
Bhandari, Abhishek ;
Stray, Sunday M. ;
Rippey, Caitlin F. ;
Roccanova, Patricia ;
Makarov, Vlad ;
Lakshmi, B. ;
Findling, Robert L. ;
Sikich, Linmarie ;
Stromberg, Thomas ;
Merriman, Barry ;
Gogtay, Nitin ;
Butler, Philip ;
Eckstrand, Kristen ;
Noory, Laila ;
Gochman, Peter ;
Long, Robert ;
Chen, Zugen ;
Davis, Sean ;
Baker, Carl ;
Eichler, Evan E. ;
Meltzer, Paul S. ;
Nelson, Stanley F. ;
Singleton, Andrew B. ;
Lee, Ming K. ;
Rapoport, Judith L. ;
King, Mary-Claire ;
Sebat, Jonathan .
SCIENCE, 2008, 320 (5875) :539-543
[85]   DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling [J].
Wilson, GM ;
Flibotte, S ;
Chopra, V ;
Melnyk, BL ;
Honer, WG ;
Holt, RA .
HUMAN MOLECULAR GENETICS, 2006, 15 (05) :743-749
[86]   Risk genes for schizophrenia: Translational opportunities for drug discovery [J].
Winchester, Catherine L. ;
Pratt, Judith A. ;
Morris, Brian J. .
PHARMACOLOGY & THERAPEUTICS, 2014, 143 (01) :34-50
[87]   Immunotherapeutic Approaches for Alzheimer's Disease [J].
Wisniewski, Thomas ;
Goni, Fernando .
NEURON, 2015, 85 (06) :1162-1176
[89]   NEUROLEPTICS AND THE NATURAL COURSE OF SCHIZOPHRENIA [J].
WYATT, RJ .
SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :325-351